Retrospective, Multi-center Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds

StimLabs

Status: Active, not recruiting

Conditions: Diabetic Ulcers; Chronic Wounds

Study type: Observational

Funder types: Industry

Identifiers

NCT07215741

REL2501.000-M (07/25)

Details and patient eligibility

About

This is a retrospective, multi-center observational study to assess real-world outcomes of StimLabs human placental membrane tissue used in the treatment of hard-to-heal wounds, including chronic ulcers, diabetic foot ulcers (DFUs), and venous leg ulcers (VLUs). The collection of retrospective real-world data provides a broad range of experiences related to patient healthcare and treatment.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Consecutive diabetic subjects that received a Relese product application during treatment between May 2023 and April 2025.

Exclusion criteria

• Subjects not receiving an initial Relese application during treatment.

Trial design

50 participants in 1 patient group

Retrospective Relese

Description:

Retrospective case review to include all subjects that received Relese between May 2023 to April 2025.